How do I prepare a 1:10,000 epinephrine solution for use in Advanced Cardiac Life Support (ACLS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Prepare 1:10,000 Epinephrine in ACLS

The 1:10,000 epinephrine solution (0.1 mg/mL) is commercially available pre-diluted and should NOT be prepared from scratch during cardiac arrest—use the pre-filled syringe directly. 1

Understanding Epinephrine Concentrations

Epinephrine comes in two standard concentrations that are critical to distinguish:

  • 1:1,000 solution = 1 mg/mL (used for IM administration in anaphylaxis)
  • 1:10,000 solution = 0.1 mg/mL (used for IV/IO administration in cardiac arrest)

The 1:10,000 concentration is supplied as 1 mg in 10 mL (0.1 mg/mL) in pre-filled syringes (ABBOJECT® Syringe). 1 This is the standard preparation used in ACLS protocols and requires no dilution.

ACLS Cardiac Arrest Dosing

For adult cardiac arrest, administer 1 mg (10 mL of the 1:10,000 solution) IV/IO every 3-5 minutes during resuscitation. 2, 3 Operationally, this means giving epinephrine every second cycle of CPR after the initial dose.

Key Administration Points:

  • For shockable rhythms (VF/pVT): Give epinephrine after the third shock if initial defibrillation attempts fail 3
  • For non-shockable rhythms (PEA/asystole): Give epinephrine as soon as vascular access is obtained 4
  • Route priority: IV or IO access are equivalent; if neither is available, endotracheal administration at 10x the IV dose (0.1 mg/kg of 1:1,000 solution) may be used, though this is less effective 4

If Dilution is Absolutely Required

In the rare circumstance where only 1:1,000 epinephrine (1 mg/mL) is available and you must create 1:10,000:

Take 1 mL of 1:1,000 epinephrine (1 mg) and add 9 mL of normal saline to create 10 mL of 1:10,000 solution (0.1 mg/mL). 5

However, this should be avoided during active resuscitation due to time delays and potential dosing errors.

Critical Safety Considerations

Concentration confusion is a common and potentially fatal error. 5 The 1:1,000 solution is 10 times more concentrated than 1:10,000. Administering 10 mL of 1:1,000 IV instead of 1:10,000 would deliver 10 mg instead of 1 mg—a dangerous overdose.

Storage and Handling:

  • Epinephrine is light-sensitive; protect from light until use 1
  • Store at room temperature 20-25°C (68-77°F) 1
  • Do not use if solution is colored, cloudy, or contains particulate matter 1
  • Avoid extravasation—can cause severe tissue necrosis 5

Post-ROSC Epinephrine Use

After return of spontaneous circulation with persistent hypotension, switch to a continuous epinephrine infusion at 0.05-2 mcg/kg/min rather than repeated boluses. 6 To prepare this infusion: dilute 1 mg of epinephrine in 1,000 mL of 5% dextrose to produce a 1 mcg/mL solution, then titrate to achieve desired mean arterial pressure. 1

Special Populations

Pediatric dosing differs significantly: 0.01 mg/kg (0.1 mL/kg of 1:10,000 solution) with a maximum single dose of 1 mg, repeated every 3-5 minutes. 4 For neonates, the dose range is 0.01-0.03 mg/kg of 1:10,000 solution. 7

Anaphylaxis dosing also differs from cardiac arrest: use 0.2-0.5 mg (0.2-0.5 mL of 1:1,000 solution) IM, NOT the 1:10,000 dilution. 6 If IV epinephrine is required for anaphylactic shock with IV access, use 0.05-0.1 mg (0.5-1 mL of 1:10,000 solution) given slowly. 6

Related Questions

How should I dilute a 1 mL ampoule of epinephrine (1 mg) with sterile normal saline to obtain a 1:10,000 or 1:100,000 solution for topical use?
Is Auvi‑Q (epinephrine) auto‑injector appropriate for infants, and what dose should be used based on their weight?
What is the appropriate management for adrenaline (epinephrine) overdose?
What is the recommended nebulised adrenaline (epinephrine) dose for infants, children, and adults?
What infusion rate of a 1:10,000 epinephrine (adrenaline) solution should be used for anaphylactic shock without cardiac arrest?
What is the appropriate evaluation and management for burning and tingling of the vagina not associated with urination in a perimenopausal woman?
Should levothyroxine (synthetic thyroxine) and Lip‑thyroxin (levothyroxine) be prescribed together?
What antidepressant should be tried next in a 33‑year‑old patient with a PHQ‑9 score of 9 who failed sertraline (Zoloft) 100 mg and escitalopram (Lexapro) due to a major breakdown, after pharmacogenomic testing?
Is desonide 0.05% (medium‑potency topical corticosteroid) the same as hydrocortisone 0.5% (low‑potency topical corticosteroid)?
What are the equivalent doses of prednisone, dexamethasone, and hydrocortisone for the standard 12‑week intravenous methylprednisolone pulse regimen (500 mg weekly for 6 weeks followed by 250 mg weekly for 6 weeks) used in active moderate‑to‑severe thyroid eye disease?
Is regular long‑term calcitonin therapy appropriate for an immobilized older adult with hypercalcemia secondary to immobility?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.